27 March 2017
Limit Sell 245 shares of MGNX @ $19.69 (0%)
Limit Sell 217 shares of RRC @ $29.10 (5%)
Limit Sell 163 shares of AA @ $38.78 (5%)
Limit Sell 1588 shares of AUO @ $4.13 (5%)
Limit Sell 296 shares of RES @ $21.30 (5%)
Limit Sell 392 shares of ACET @ $16.11 (5%)
Limit Sell 367 shares of HCLP @ $17.45 (5%)
Limit Sell 901 shares of MDR @ $7.00 (5%)
Limit Sell 357 shares of DNOW @ $17.69 (5%)
Another positive day while market is down -- now that's strength. Be patient; we're upside down on a lot but these stocks but they will outperform the market.
MGNX - Systematic investing. 5% and out. Target Price $30.00
**UPDATE** MGNX is a clinical stage pharmaceutical that has found it's floor and should pick up serious traction sometime this year. It essentially floats between $19-$21...so there's some room to work around that price with buying low, selling high. Could easily be trading @ $40 sometime this year.
AA - Systematic investing. 5% and out.
AUO - Systematic investing. 5% and out.
RES - Systematic investing. 5% and out.
ACET - Systematic investing. 5% and out.
HK - Systematic investing. 5% and out.
RRC - Systematic investing. 5% and out.
MDR - Systematic investing. 5% and out.
HCLP - Systematic investing. 5% and out.
**UPDATE** This stock is only under performing because oil prices went down. Don't panic...ride the wave...it might be a little long that we wanted, but don't sell out early.
VSTM - Sold @ $1.39. Desired re-entry @ $1.30. Target Price $2.50
DNOW - Systematic investing. 5% and out.
IPXL - Monitoring for sub $8.50 price; probably won't happen.
UA - We still really like the position of UA for a gain, but we felt like we could sell on this, purchase something else, and return to UA at a cheaper price than $19.03 which would be a double win.
TRVN - Monitoring. At this time, we don't recommend.
SHOP - Sold @ $54.48. Need re-entry below to make it make sense. Target Price $65.00
USB - Sold @ $53.60. Need re-entry below to make it make sense. Target Price $70.00
SSW - The whole shipping industry is suffering as a whole right now, but when, not if, it recovers Seaspan will once again lead the pack. Still a little risky at the moment. Monitoring.
CAB - We aren't in business of fighting with stocks or pride; we sold because CAB mostly likely isn't going to do anything positive for the next two months. If we can get a re-entry of 191 shares @ a price below $47.70, it's a win. Monitoring. First loss of the year.
DRYS - Beware of this stock. Monitoring for future.
NFX - Back from the dead, NFX is looking better than ever. Probably my favorite stock going into the following trading days.
RLGT - Monitoring. This stock is a little out of our wheelhouse -- massive growth expected...not expected overnight.